The global CAR T-cell therapy market is witnessing substantial growth, driven by increasing incidence of cancer and positive regulatory approvals. Major players in the market are engaging in development to enhance their product portfolio and address the growing requirement for effective cancer treatments. Furthermore, advancements in CAR T-cell th